A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old

Clinical trial NCT06944717 · COMPLETED

Trial details

NCT number: NCT06944717
Sponsor: Vaxart
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Norovirus Infections

Start date: 2025-03-03
Primary completion: 2026-04-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.